Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02069756 · ClinicalTrials.gov registry record
The Duchenne Registry
A clinical trial of Duchenne Muscular Dystrophy and Becker Muscular Dystrophy, sponsored by The Duchenne Registry.
- Recruiting
- Registry status
- 10,000
- Enrollment target
- 1
- Study location
NCT02069756 is a study of Duchenne Muscular Dystrophy and Becker Muscular Dystrophy that is actively recruiting participants, run by The Duchenne Registry. The registered enrollment target is 10,000 participants, above the 204-participant average among 48 other Duchenne Muscular Dystrophy trials with a reported enrollment target (4802% higher). The trial reports 1 study location across 1 state.
The verdict
NCT02069756, a study of Duchenne Muscular Dystrophy and Becker Muscular Dystrophy, is actively recruiting participants, sponsored by The Duchenne Registry.
- RECRUITING
- Registry status
- 10,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The Duchenne Registry is an online, patient-report registry for individuals with Duchenne and Becker muscular dystrophy and carrier females. The purpose of the Registry is to connect Duchenne and Becker patients with actively recruiting clinical trials and research studies, and to educate patients and families about Duchenne and Becker care and research. At the same time, The Duchenne Registry is a valuable resource for clinicians and researchers in academia and industry, allowing access to de-identified datasets provided by patients and their families-information that is vital to advances in the care and treatment of Duchenne. The Duchenne Registry is a member of the TREAT-NMD Neuromuscular Network.
Conditions Studied
Study Locations (1)
District of Columbia
- The Duchenne Registry / PPMD - Washington D.C.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10,000 participants |
| Start Date | 2007-10 |
| Est. Completion | 2047-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02069756
The ClinicalTrials.gov registry entry for NCT02069756 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 10,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 204-participant average among 48 other Duchenne Muscular Dystrophy trials with a reported enrollment target (4802% higher). The listed sponsor is The Duchenne Registry, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Duchenne Muscular Dystrophy appearing as the primary indexed condition, and to 0 interventions.
NCT02069756 reports 1 study location spanning 1 distinct geographic area - top geographies include District of Columbia.
Frequently Asked Questions
What is clinical trial NCT02069756 about?
NCT02069756 is a clinical study titled "The Duchenne Registry". The Duchenne Registry is an online, patient-report registry for individuals with Duchenne and Becker muscular dystrophy and carrier females. The purpose of the Registry is to connect Duchenne and Becker patients with actively recruiting clinical trials and research studies, and to educate patients a...
What is the current status of trial NCT02069756?
This trial is currently recruiting. The enrollment target is 10,000 participants. The study started on 2007-10. Estimated completion is 2047-10.
What conditions does trial NCT02069756 study?
This clinical trial studies the following conditions: Duchenne Muscular Dystrophy, Becker Muscular Dystrophy.
Who is sponsoring clinical trial NCT02069756?
This trial is sponsored by The Duchenne Registry, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02069756 being conducted?
This trial has 1 study location across District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Duchenne Muscular Dystrophy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)
RECRUITING · Phase 1
-
AFFINITY DUCHENNE: RGX-202 Gene Therapy in Participants With Duchenne Muscular Dystrophy (DMD)
RECRUITING · Phase 2
-
A Study to Assess the Efficacy and Safety of Satralizumab in Duchenne Muscular Dystrophy (DMD)
RECRUITING · Phase 2
-
Phase 2 Study of SAT-3247 in Pediatric Ambulatory Patients
RECRUITING · Phase 2
-
Once Weekly Infant Corticosteroid Trial for DMD
RECRUITING · Phase 4
-
Wearable Technology to Evaluate Hyperglycemia and HRV in DMD - Longitudinal Aim
RECRUITING
Explore more on PlainTrial
Duchenne Muscular Dystrophy
All registered trials for this condition
Becker Muscular Dystrophy
All registered trials for this condition
District of Columbia
All trials with a study site in District of Columbia
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.